The Innovators: Inflection BioSciences

Meet Darren Cunningham, CEO of Inflection BioSciences, an early-stage drug development company focused on discovering and developing innovative small molecule therapeutics to treat cancer and cancer recurrences.

0 Comments

Submit a Comment

Your email address will not be published.

Share YOUR Cancer Story
Celebrate You Hero